Neil Kumar, Director, Chief Executive Officer, on May 21, 2026, sold 26,103 shares in Bridgebio Pharma (BBIO) for $1,812,522. Following the Form 4 filing with the SEC, Kumar has control over a total of 5,157,460 common shares of the company, with 243,327 shares held directly and 4,914,133 controlled indirectly.
SEC Filing: